Mauricio Burotto

8PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 25, 2026
First-Line Treatment Strategies in IMDC Favourable-Risk Metastatic Clear Cell Renal Cell Carcinoma.

|Apr 07, 2026
Subcutaneous atezolizumab for the treatment of non-small cell lung cancer.

Jaime González-Montero, Carlos I Rojas, Mauricio Burotto

|Feb 13, 2025
Understanding microRNA-Mediated Chemoresistance in Colorectal Cancer Treatment.

Guillermo Valenzuela, Héctor R Contreras, Katherine Marcelain

|Dec 13, 2024
Targeting HIF-2α: the role of belzutifan in clear cell renal carcinoma management.

Alejandro Valdés, Gonzalo Pizarro, Jaime González-Montero

|Jun 26, 2024
Predictors of response to immunotherapy in colorectal cancer.

Jaime González-Montero, Carlos I Rojas, Mauricio Burotto

|May 11, 2024
Distinct Driver Pathway Enrichments and a High Prevalence of TSC2 Mutations in Right Colon Cancer in Chile: A Preliminary Comparative Analysis.

Camilo Tapia-Valladares, Guillermo Valenzuela, Evelin González

Pageof 2

Frequent Collaborators

4 joint publications

Mauricio Burotto

2 joint publications

Héctor R Contreras

2 joint publications

Katherine Marcelain

2 joint publications

Alejandro Valdés